Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clay

Showing results (261-270 of 326) with videos related to

Pageof 33
Sort By:
Blood|August 15, 1996
Molecular characterization of antigenic polymorphisms (Ond(a) and Mart(a)) of the beta 2 family recognized by human leukocyte alloantiseraS Simsek, C E van der Schoot, M Daams, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine ConsortiumCedrik Michael Britten, Sylvia Janetzki, Leah Ben-Porat, et al.
International Journal of Gastrointestinal Cancer|March 13, 2003
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancerMichael A Morse, Smita K Nair, David Boczkowski, et al.
International Journal of Epidemiology|June 1, 1988
Education, smoking and non-cardiovascular mortality: findings in three Chicago epidemiological studiesC M Clay, A R Dyer, K Liu, et al.
Journal of Translational Medicine|September 8, 2007
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A Morse, Amy Hobeika, Takuya Osada, et al.
Cancer Gene Therapy|February 21, 2009
Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunityT Osada, X Y Yang, Z C Hartman, et al.
Frontiers in Endocrinology|August 13, 2025
Evidence for divergent endocrine regulation of the murine and ovine GnRH receptor gene promotersChristianne Magee, Jennifer E Kouri, Brian D Cherrington, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplantsMichael A Morse, David Rizzieri, Timothy T Stenzel, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 1991
Estradiol inhibits transcription of the human glycoprotein hormone alpha-subunit gene despite the absence of a high affinity binding site for estrogen receptorR A Keri, B Andersen, G C Kennedy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2019
The Landscape of Early Clinical Gene Therapies outside of OncologyLaure Rittié, Takis Athanasopoulos, Miguel Calero-Garcia, et al.
Pageof 33

Showing results (261-270 of 326) with videos related to

Sort By:
Pageof 33
Blood|August 15, 1996
Molecular characterization of antigenic polymorphisms (Ond(a) and Mart(a)) of the beta 2 family recognized by human leukocyte alloantiseraS Simsek, C E van der Schoot, M Daams, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2009
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine ConsortiumCedrik Michael Britten, Sylvia Janetzki, Leah Ben-Porat, et al.
International Journal of Gastrointestinal Cancer|March 13, 2003
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancerMichael A Morse, Smita K Nair, David Boczkowski, et al.
International Journal of Epidemiology|June 1, 1988
Education, smoking and non-cardiovascular mortality: findings in three Chicago epidemiological studiesC M Clay, A R Dyer, K Liu, et al.
Journal of Translational Medicine|September 8, 2007
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A Morse, Amy Hobeika, Takuya Osada, et al.
Cancer Gene Therapy|February 21, 2009
Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunityT Osada, X Y Yang, Z C Hartman, et al.
Frontiers in Endocrinology|August 13, 2025
Evidence for divergent endocrine regulation of the murine and ovine GnRH receptor gene promotersChristianne Magee, Jennifer E Kouri, Brian D Cherrington, et al.
Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplantsMichael A Morse, David Rizzieri, Timothy T Stenzel, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 1991
Estradiol inhibits transcription of the human glycoprotein hormone alpha-subunit gene despite the absence of a high affinity binding site for estrogen receptorR A Keri, B Andersen, G C Kennedy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2019
The Landscape of Early Clinical Gene Therapies outside of OncologyLaure Rittié, Takis Athanasopoulos, Miguel Calero-Garcia, et al.
Pageof 33